// App-Quantinova.ai

: Modification of the SUPT3H/RUNX2-dmr using CRISPR/Cas9 demonstrates functional regulation of RUNX2 expression

Researchers

Presenter

  • S.J. Rice

Principal Investigators

  • G. Aubourg

  • A.K. Sorial

  • M. Tselepi

  • D. Almarza

  • D. Deehan

  • L.N. Reynard

  • J. Loughlin

Medical Centers

  • Newcastle University, Newcastle upon Tyne, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Genetic Disorder

Disease

  • Paragangliomas 3

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved